Literature DB >> 22729149

Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR.

Baran A Ersoy1, Leonardo Pardo, Sumei Zhang, Darren A Thompson, Glenn Millhauser, Cedric Govaerts, Christian Vaisse.   

Abstract

Most of our understanding of G protein-coupled receptor (GPCR) activation has been focused on the direct interaction between diffusible ligands and their seven-transmembrane domains. However, a number of these receptors depend on their extracellular N-terminal domain for ligand recognition and activation. To dissect the molecular interactions underlying both modes of activation at a single receptor, we used the unique properties of the melanocortin-4 receptor (MC4R), a GPCR that shows constitutive activity maintained by its N-terminal domain and is physiologically activated by the peptide α-melanocyte stimulating hormone (αMSH). We find that activation by the N-terminal domain and αMSH relies on different key residues in the transmembrane region. We also demonstrate that agouti-related protein, a physiological antagonist of MC4R, acts as an inverse agonist by inhibiting N terminus-mediated activation, leading to the speculation that a number of constitutively active orphan GPCRs could have physiological inverse agonists as sole regulators.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729149      PMCID: PMC3657613          DOI: 10.1038/nchembio.1008

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  39 in total

1.  Use of constitutive G protein-coupled receptor activity for drug discovery.

Authors:  G Chen; J Way; S Armour; C Watson; K Queen; C K Jayawickreme; W J Chen; T Kenakin
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

Review 2.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.

Authors:  Roland Seifert; Katharina Wenzel-Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-06       Impact factor: 3.000

3.  Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.

Authors:  C Haskell-Luevano; R D Cone; E K Monck; Y P Wan
Journal:  Biochemistry       Date:  2001-05-22       Impact factor: 3.162

Review 4.  Efficacy as a vector: the relative prevalence and paucity of inverse agonism.

Authors:  Terry Kenakin
Journal:  Mol Pharmacol       Date:  2004-01       Impact factor: 4.436

Review 5.  The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool.

Authors:  D P Behan; D T Chalmers
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

6.  Structure of an agonist-bound human A2A adenosine receptor.

Authors:  Fei Xu; Huixian Wu; Vsevolod Katritch; Gye Won Han; Kenneth A Jacobson; Zhan-Guo Gao; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2011-03-10       Impact factor: 47.728

7.  AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor.

Authors:  W A Nijenhuis; J Oosterom; R A Adan
Journal:  Mol Endocrinol       Date:  2001-01

8.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch.

Authors:  Lei Shi; George Liapakis; Rui Xu; Frank Guarnieri; Juan A Ballesteros; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

9.  Inverse agonist activity of agouti and agouti-related protein.

Authors:  Biao-Xin Chai; Richard R Neubig; Glenn L Millhauser; Darren A Thompson; Pilgrim J Jackson; Gregory S Barsh; Chris J Dickinson; Ji-Yao Li; Yu-Mei Lai; Ira Gantz
Journal:  Peptides       Date:  2003-04       Impact factor: 3.750

10.  Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations.

Authors:  Cecile Lubrano-Berthelier; Emmanuelle Durand; Beatrice Dubern; Astrid Shapiro; Paul Dazin; Jacques Weill; Camille Ferron; Philippe Froguel; Christian Vaisse
Journal:  Hum Mol Genet       Date:  2003-01-15       Impact factor: 6.150

View more
  16 in total

Review 1.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

2.  Dynamic roles for the N-terminus of the yeast G protein-coupled receptor Ste2p.

Authors:  M Seraj Uddin; Fred Naider; Jeffrey M Becker
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-07-25       Impact factor: 3.747

3.  The multifaceted melanocortin receptors.

Authors:  Linda Laiho; Joanne Fiona Murray
Journal:  Endocrinology       Date:  2022-06-14       Impact factor: 5.051

4.  Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight.

Authors:  Yi Wang; Adelaide Bernard; Fanny Comblain; Xinyu Yue; Christophe Paillart; Sumei Zhang; Jeremy F Reiter; Christian Vaisse
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

5.  The N-terminus of the yeast G protein-coupled receptor Ste2p plays critical roles in surface expression, signaling, and negative regulation.

Authors:  M Seraj Uddin; Melinda Hauser; Fred Naider; Jeffrey M Becker
Journal:  Biochim Biophys Acta       Date:  2015-12-17

6.  Melanocortin 4 receptor becomes an ACTH receptor by coexpression of melanocortin receptor accessory protein 2.

Authors:  Maria Josep Agulleiro; Raúl Cortés; Begoña Fernández-Durán; Sandra Navarro; Raúl Guillot; Eirini Meimaridou; Adrian J L Clark; José Miguel Cerdá-Reverter
Journal:  Mol Endocrinol       Date:  2013-10-01

7.  Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.

Authors:  Bethany A Falls; Yan Zhang
Journal:  ACS Chem Neurosci       Date:  2018-08-13       Impact factor: 4.418

8.  Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism.

Authors:  Katerina Spyridaki; Minos-Timotheos Matsoukas; Arnau Cordomi; Kostas Gkountelias; Maria Papadokostaki; Thomas Mavromoustakos; Diomedes E Logothetis; Andrew N Margioris; Leonardo Pardo; George Liapakis
Journal:  J Biol Chem       Date:  2014-05-16       Impact factor: 5.157

9.  Ligand chain length drives activation of lipid G protein-coupled receptors.

Authors:  Anastassia Troupiotis-Tsaïlaki; Julian Zachmann; Inés González-Gil; Angel Gonzalez; Silvia Ortega-Gutiérrez; Maria L López-Rodríguez; Leonardo Pardo; Cedric Govaerts
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

10.  Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin.

Authors:  Sara Gómez-Melero; Fé Isabel García-Maceira; Tania García-Maceira; Verónica Luna-Guerrero; Gracia Montero-Peñalvo; Isaac Túnez-Fiñana; Elier Paz-Rojas
Journal:  BMC Biotechnol       Date:  2021-07-05       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.